Treatment of human immunodeficiency virus infections
- 1 June 1987
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (6), 839-843
- https://doi.org/10.1128/aac.31.6.839
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- RESPONSE OF HUMAN-IMMUNODEFICIENCY-VIRUS-ASSOCIATED NEUROLOGICAL DISEASE TO 3'-AZIDO-3'-DEOXYTHYMIDINEThe Lancet, 1987
- Both 2′,3′-dideoxythymidine and its 2′,3′-unsaturated derivative (2′,3′-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitroBiochemical and Biophysical Research Communications, 1987
- In Vitro Suppression of HTLV-III/LAV Infectivity by a Combination of Acyclovir and SuraminThe Journal of Infectious Diseases, 1986
- Prospects for the Prevention and Therapy of Infections with the Human Immunodeficiency VirusClinical Infectious Diseases, 1986
- Potent and selective anti-HTLV-IIILAV activity of 2′,3′-dideoxycytidinene, the 2′,3′-unsaturated derivative of 2′,3′-dideoxycytidineBiochemical and Biophysical Research Communications, 1986
- Recombinant human interferon gamma suppresses HTLV‐III replication in vitroInternational Journal of Cancer, 1986
- Human Alpha- and Beta-Interferon But Not Gamma- Suppress theIn VitroReplication of LAV, HTLV-III, and ARV-2Journal of Interferon Research, 1986
- INHIBITION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE III IN VITRO BY PHOSPHONOFORMATEThe Lancet, 1985
- RECOMBINANT HUMAN INTERFERON ALFA-A SUPPRESSES HTLV-III REPLICATION IN VITROThe Lancet, 1985
- RIBAVIRIN SUPPRESSES REPLICATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS IN CULTURES OF HUMAN ADULT T LYMPHOCYTESThe Lancet, 1984